Position in VYGR
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$392,645
-$128,719 QoQ
Shares Held
101,722
-23.3% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $1,293,435,833 across 390 Biotechnology names. VYGR ranks #137 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
744,995 | $332,670,066 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
342,763 | $113,409,991 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
142,021 | $109,731,102 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
1,535,737 | $99,254,679 | |
| 5 | INSM |
INSMED Inc
|
597,384 | $97,684,229 | |
| 6 | ASND |
Ascendis Pharma A/S
|
154,199 | $35,269,936 | |
| 7 | EXEL |
Exelixis, Inc.
|
687,304 | $29,478,466 | |
| 8 | ARGX |
Argenx SE
|
38,104 | $27,825,444 |
All Filings in VYGR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $392,645 | 101,722 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $521,364 | 132,663 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $488,942 | 104,699 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $184,331 | 59,271 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $190,533 | 56,371 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $378,290 | 66,718 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $376,259 | 64,318 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $506,397 | 64,020 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $537,557 | 57,740 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $81,994 | 9,715 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $60,775 | 7,842 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $171,314 | 14,962 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $15,927 | 2,066 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,583 | 2,063 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,756 | 2,324 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $29,046 | 4,915 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $42,655 | 5,598 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $91,011 | 33,584 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $148,549 | 56,483 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $414,002 | 100,243 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $369,054 | 78,356 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,006,125 | 140,717 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $4,626,126 | 433,564 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,856,044 | 464,029 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,189,839 | 457,906 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||